Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.33
+0.02 (0.32%)
Jan 23, 2026, 11:30 AM CST
Daan Gene Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 756.21 | 843.75 | 1,173 | 12,040 | 7,615 | 5,330 | Upgrade |
Other Revenue | 9.27 | 9.27 | 8 | 6.08 | 48.84 | 10.93 | Upgrade |
| 765.48 | 853.02 | 1,181 | 12,046 | 7,664 | 5,341 | Upgrade | |
Revenue Growth (YoY) | -17.66% | -27.77% | -90.20% | 57.17% | 43.49% | 386.35% | Upgrade |
Cost of Revenue | 613.85 | 629.58 | 801.12 | 3,615 | 1,963 | 1,605 | Upgrade |
Gross Profit | 151.63 | 223.44 | 379.78 | 8,431 | 5,701 | 3,736 | Upgrade |
Selling, General & Admin | 377.72 | 333.32 | 300.68 | 1,246 | 1,124 | 888.63 | Upgrade |
Research & Development | 204.42 | 225.67 | 302.33 | 702.4 | 508.8 | 166.95 | Upgrade |
Other Operating Expenses | -13.96 | -18.22 | -8.56 | 101.03 | 36.34 | -9.57 | Upgrade |
Operating Expenses | 888.89 | 936.47 | 735.82 | 2,347 | 1,800 | 1,191 | Upgrade |
Operating Income | -737.27 | -713.02 | -356.04 | 6,084 | 3,901 | 2,545 | Upgrade |
Interest Expense | -6.75 | -9.74 | -10.04 | -13.94 | -9.35 | -22.44 | Upgrade |
Interest & Investment Income | 53.45 | 69.37 | 83.1 | 370.86 | 266.7 | 154.27 | Upgrade |
Currency Exchange Gain (Loss) | 5.85 | 5.85 | 2.28 | 25.72 | -1.85 | -9.3 | Upgrade |
Other Non Operating Income (Expenses) | -12.39 | -4.07 | -12.77 | -22.07 | -12.56 | -31.81 | Upgrade |
EBT Excluding Unusual Items | -697.12 | -651.62 | -293.48 | 6,445 | 4,144 | 2,635 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -4.2 | Upgrade |
Gain (Loss) on Sale of Investments | 21.31 | -429.58 | 409.44 | 73.97 | -83.78 | 286.23 | Upgrade |
Gain (Loss) on Sale of Assets | 9.55 | 9.1 | -3.04 | -1.15 | 0.11 | 0.14 | Upgrade |
Asset Writedown | -18.21 | -10.65 | -59.48 | -256.35 | -15 | -14.52 | Upgrade |
Legal Settlements | 0.07 | 0.07 | 1.42 | 0.46 | - | - | Upgrade |
Other Unusual Items | 11.52 | 11.52 | 58.67 | 57.22 | 74.44 | -0.05 | Upgrade |
Pretax Income | -672.86 | -1,071 | 113.54 | 6,319 | 4,120 | 2,903 | Upgrade |
Income Tax Expense | -84.47 | -132.05 | 41.8 | 891.38 | 501.59 | 452.82 | Upgrade |
Earnings From Continuing Operations | -588.39 | -939.11 | 71.73 | 5,428 | 3,618 | 2,450 | Upgrade |
Net Income to Company | -588.39 | -939.11 | 71.73 | 5,428 | 3,618 | 2,450 | Upgrade |
Minority Interest in Earnings | 24.43 | 13.94 | 32.93 | -15.22 | -0.3 | -0.95 | Upgrade |
Net Income | -563.95 | -925.17 | 104.66 | 5,412 | 3,618 | 2,449 | Upgrade |
Net Income to Common | -563.95 | -925.17 | 104.66 | 5,412 | 3,618 | 2,449 | Upgrade |
Net Income Growth | - | - | -98.07% | 49.59% | 47.74% | 2556.80% | Upgrade |
Shares Outstanding (Basic) | 1,416 | 1,402 | 1,495 | 1,403 | 1,403 | 1,403 | Upgrade |
Shares Outstanding (Diluted) | 1,416 | 1,402 | 1,495 | 1,403 | 1,403 | 1,403 | Upgrade |
Shares Change (YoY) | -4.97% | -6.25% | 6.53% | - | - | - | Upgrade |
EPS (Basic) | -0.40 | -0.66 | 0.07 | 3.86 | 2.58 | 1.75 | Upgrade |
EPS (Diluted) | -0.40 | -0.66 | 0.07 | 3.86 | 2.58 | 1.75 | Upgrade |
EPS Growth | - | - | -98.19% | 49.59% | 47.74% | 2556.82% | Upgrade |
Free Cash Flow | -3.01 | 125.92 | 207.34 | 2,652 | 2,646 | 2,150 | Upgrade |
Free Cash Flow Per Share | -0.00 | 0.09 | 0.14 | 1.89 | 1.89 | 1.53 | Upgrade |
Dividend Per Share | - | - | 0.015 | 1.750 | 1.110 | 0.344 | Upgrade |
Dividend Growth | - | - | -99.14% | 57.66% | 222.86% | 2321.13% | Upgrade |
Gross Margin | 19.81% | 26.19% | 32.16% | 69.99% | 74.39% | 69.94% | Upgrade |
Operating Margin | -96.31% | -83.59% | -30.15% | 50.51% | 50.90% | 47.64% | Upgrade |
Profit Margin | -73.67% | -108.46% | 8.86% | 44.93% | 47.21% | 45.85% | Upgrade |
Free Cash Flow Margin | -0.39% | 14.76% | 17.56% | 22.02% | 34.52% | 40.25% | Upgrade |
EBITDA | -402.61 | -374.26 | -11.82 | 6,347 | 4,093 | 2,617 | Upgrade |
EBITDA Margin | -52.60% | -43.88% | -1.00% | 52.69% | 53.41% | 48.99% | Upgrade |
D&A For EBITDA | 334.66 | 338.76 | 344.23 | 262.88 | 192.02 | 72 | Upgrade |
EBIT | -737.27 | -713.02 | -356.04 | 6,084 | 3,901 | 2,545 | Upgrade |
EBIT Margin | -96.31% | -83.59% | -30.15% | 50.51% | 50.90% | 47.64% | Upgrade |
Effective Tax Rate | - | - | 36.82% | 14.11% | 12.17% | 15.60% | Upgrade |
Revenue as Reported | 765.48 | 853.02 | 1,181 | 12,046 | 7,664 | 5,341 | Upgrade |
Advertising Expenses | - | - | - | - | - | 1.38 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.